Clinical Trials · NCT07251556
GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Chinese University of Hong Kong
- Enrollment
- 40
- Start date
- Dec 2025
- Locations
- See registry
- Primary endpoint
- Difference in the proportion of subjects with CIMT between the semaglutide group and control group over a period of 24 weeks.